Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on visible light photocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel visible-light method for 1,2-allenyl ketones offering mild conditions and broad substrate scope for reliable pharmaceutical intermediate supply chains.
Patent CN110183394B reveals a mild photocatalytic route for 3-nitrile ethyl-2-hydrocarbyl-4H-benzoxazine, offering safer cyanation and scalable manufacturing for global supply chains.
Patent CN110183394B details a mild photocatalytic route for 3-nitrile ethyl-2-hydrocarbyl-4H-benzoxazine, offering cost-effective API intermediate manufacturing.
Patent CN115057794B enables visible light-induced demethylation. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN108586283B reveals a green visible-light method using Rose Bengal, eliminating metal oxidants for safer pharmaceutical intermediate manufacturing.
Patent CN119431386A reveals photocatalytic synthesis enabling cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable green chemistry processes.
Visible light photocatalysis method for beta-methoxy fatty acid esters. Metal-free, green process offering supply chain stability and cost efficiency for fine chemical manufacturing.
Patent CN111269228A reveals a green photocatalytic route for fluorescent indolizine derivatives, offering cost-effective manufacturing for pharma intermediates.
Patent CN111777477A details a mild visible-light method for synthesizing succinic acid derivatives and 3-arylpropionic acids using CO2, offering significant cost and safety advantages.
Patent CN108083999B details a visible-light catalyzed route for alpha-hydroxy ketones, offering cost reduction and green manufacturing advantages for pharmaceutical intermediates.
Patent CN107353245A enables metal-free quinoline production. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN118459319A introduces visible light catalysis for biphenols. Offers green synthesis, cost reduction, and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN108752232B details a green photocatalytic method for alpha-quaternary amino acids using CO2, offering safer alternatives to toxic Strecker reactions for pharma supply chains.
Novel photosensitizer-free method for 2-amino-1,4-naphthoquinone derivatives offering green synthesis and supply chain efficiency for pharmaceutical intermediates.
Patent CN107899611A enables visible light asymmetric hydroxylation using molecular oxygen. Delivers cost reduction and supply chain reliability for agrochemical intermediate manufacturing.
Patent CN107899611A introduces a visible light organocatalyst for asymmetric hydroxylation, offering cost reduction and supply chain reliability for agrochemical intermediate manufacturing.
Patent CN110105293B details a visible-light driven method for synthesizing C-3 difluoromethyl quinoxalinones, offering a greener, safer route for pharmaceutical intermediate manufacturing.
Patent CN116789664A details a metal-free photocatalytic route for trifluoromethyl benzimidazoloisoquinoline analogues, offering cost-effective and scalable manufacturing solutions.
Novel visible-light induced method for quinoxalines using non-activated amines. Cost-effective, green synthesis for reliable pharmaceutical intermediate supply chain.
Patent CN118851967A details a green visible light method for trifluoromethylselenosylstyrene derivatives, offering cost reduction and supply chain reliability for pharmaceutical intermediates.